The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Godrej Properties Limited: Consolidated Financials for Q2 FY24 Results
Bangalore,3rd November 2023: Godrej Properties Limited (GPL), a leading national real estate developer, announced its financial results for the second…
A Preview of Professional Life With JUMP-IN
The patient’s vital signs were dropping. A Tufts University first-year student leaned over the hospital bed, scanning a monitor and…
Eplan Next26: Inspiring insights into the future of engineering
Around 1,500 attendees from 36 countries, renowned keynote speakers, fascinating panel discussions and interesting insights into the future…